Literature DB >> 6102234

Return of fertility after discontinuation of depot medroxyprogesterone acetate and intra-uterine devices in Northern Thailand.

T Pardthaisong, R H Gray, E B McDaniel.   

Abstract

796 Thai women who stopped using the long-acting injectable contraceptive 'Depo-Provera' (medroxyprogesterone acetate) and 125 women who had an intra-uterine device removed to have a planned pregnancy were followed-up to ascertain the delay between conception and the end of contraception, and to determine the proportion of women who did not conceive in the 2 years after discontinuation. The median delay before conception was 5.5 months plus the estimated duration of the effect of the last injection of depo-provera and 4.5 months after discontinuing the IUD. Since depo-provera acts for approximately 15 weeks, women can except a median delay to conception of around 9 months after their last injection. The proportions of women who did not conceive within 1 year and within 2 years of stopping contraception by the two methods were similar. There was no evidence to suggest that prolonged use of depo-provera increases the delay before conception, and the return of fertility among never pregnant ex-users resembled that of ever pregnant ex-users.

Entities:  

Keywords:  Age Factors; Asia; Biology; Contraception; Contraception Termination; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Demographic Factors; Depo-provera; Developing Countries; Endocrine System; Family Planning; Fecundability; Fecundity; Fertility; Fertility Measurements; Hormones; Injectables; Iud; Medroxyprogesterone Acetate; Parity; Physiology; Population; Population Dynamics; Pregnancy Intervals; Pregnancy, Planned; Reproduction; Reproductive Behavior; Reproductive Control Agents; Research Report; Reversibility; Southeastern Asia; Thailand

Mesh:

Substances:

Year:  1980        PMID: 6102234     DOI: 10.1016/s0140-6736(80)92765-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  12 in total

Review 1.  Contraception.

Authors:  A Szarewski; J Guillebaud
Journal:  BMJ       Date:  1991-05-25

2.  Are long working hours and shiftwork risk factors for subfecundity? A study among couples from southern Thailand.

Authors:  P Tuntiseranee; J Olsen; A Geater; O Kor-anantakul
Journal:  Occup Environ Med       Date:  1998-02       Impact factor: 4.402

3.  Depo-Provera--ethical issues in its testing and distribution.

Authors:  M Potts; J M Paxman
Journal:  J Med Ethics       Date:  1984-03       Impact factor: 2.903

4.  Facts about injectable contraceptives: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1982       Impact factor: 9.408

5.  Does bacterial vaginosis modify the effect of hormonal contraception on HIV seroconversion.

Authors:  Michelle C Sabo; Barbra A Richardson; Ludo Lavreys; Harold L Martin; Walter Jaoko; Kishorchandra Mandaliya; Jared M Baeten; Julie Overbaugh; R Scott McClelland
Journal:  AIDS       Date:  2019-06-01       Impact factor: 4.177

6.  A prospective cohort study of the effect of depot medroxyprogesterone acetate on detection of plasma and cervical HIV-1 in women initiating and continuing antiretroviral therapy.

Authors:  Summer Day; Susan M Graham; Linnet N Masese; Barbra A Richardson; James N Kiarie; Walter Jaoko; Kishorchandra Mandaliya; Vrasha Chohan; Julie Overbaugh; R Scott McClelland
Journal:  J Acquir Immune Defic Syndr       Date:  2014-08-01       Impact factor: 3.731

7.  Hormonal contraceptive use and risk of HIV-1 disease progression.

Authors:  Renee Heffron; Nelly Mugo; Kenneth Ngure; Connie Celum; Deborah Donnell; Edwin Were; Helen Rees; James Kiarie; Jared M Baeten
Journal:  AIDS       Date:  2013-01-14       Impact factor: 4.177

Review 8.  Combination injectable contraceptives for contraception.

Authors:  Maria F Gallo; David A Grimes; Laureen M Lopez; Kenneth F Schulz; Catherine d'Arcangues
Journal:  Cochrane Database Syst Rev       Date:  2008-10-08

Review 9.  Long acting contraceptives. Present status.

Authors:  G Benagiano; F M Primiero
Journal:  Drugs       Date:  1983-06       Impact factor: 9.546

10.  Simulated clients reveal programmatic factors that may influence contraceptive use in Kisumu, Kenya.

Authors:  Katherine Tumlinson; Ilene Speizer; Linda Archer; Frieda Behets
Journal:  Glob Health Sci Pract       Date:  2013-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.